RSS   Newsletter   Contact   Advertise with us

Medivir appoints Christina Herder as executive vice president

Share on Twitter Share on LinkedIn
Staff Writer | Stockholm, Sweden | November 14, 2017
Christina HerderNovember 14, 2017, Stockholm, Sweden - Medivir, a pharmaceutical company, announced the appointment of Christina Herder, as executive vice president, strategic business development effective December 14, 2017.
Ms. Herder has 25 years experience of supporting drug development in the areas of corporate and business development, strategy and project management.

Her most recent employment was as CEO of Modus Therapeutics.

Prior to Modus, Ms. Herder held various leadership positions at Sobi AB (and previously Biovitrum), including in Corporate Development, Licensing, and Portfolio and Project Management.

She began her career at Pharmacia & Upjohn.

Ms. Herder earned a PhD in Physical Chemistry from the Royal Institute of Technology from KTH in Stockholm, and holds an MBA from Stockholm University.